Waters Cash Flow from Investing Activities 2010-2024 | WAT
Waters annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
- Waters cash flow from investing activities for the quarter ending December 31, 2024 was $-0.144B, a 90.01% decline year-over-year.
- Waters cash flow from investing activities for the twelve months ending December 31, 2024 was $-0.332B, a 92.2% decline year-over-year.
- Waters annual cash flow from investing activities for 2024 was $-0.144B, a 90.01% decline from 2023.
- Waters annual cash flow from investing activities for 2023 was $-1.442B, a 1235.84% increase from 2022.
- Waters annual cash flow from investing activities for 2022 was $-0.108B, a 53.39% decline from 2021.
| Waters Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $-144 |
| 2023 | $-1,442 |
| 2022 | $-108 |
| 2021 | $-232 |
| 2020 | $-264 |
| 2019 | $769 |
| 2018 | $1,683 |
| 2017 | $-536 |
| 2016 | $-488 |
| 2015 | $-400 |
| 2014 | $-402 |
| 2013 | $-465 |
| 2012 | $-296 |
| 2011 | $-356 |
| 2010 | $-412 |
| 2009 | $-419 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $20.850B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||